Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cannara Biotech Inc (OP: LOVFF ) 0.4932 UNCHANGED Streaming Delayed Price Updated: 12:18 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.4932 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.4932 Today's Range 0.4932 - 0.4932 52wk Range 0.4700 - 0.8375 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going June 03, 2024 In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable... Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss May 01, 2024 Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68%... Via Benzinga Topics Cannabis Exposures Cannabis Performance YTD -21.04% -21.04% 1 Month -2.34% -2.34% 3 Month -20.96% -20.96% 6 Month -19.23% -19.23% 1 Year -29.54% -29.54% More News Read More This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices December 20, 2023 Via News Direct Topics Cannabis Exposures Cannabis The 7 Most Undervalued Cannabis Stocks to Buy in December December 14, 2023 Via InvestorPlace Topics Cannabis Exposures Cannabis This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices December 07, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis 7 Smoking-Hot 420 Stocks to Buy in 2023 August 17, 2023 Via InvestorPlace Topics Cannabis Exposures Cannabis Cannabis Stock Movers For August 10, 2023 August 10, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA? July 27, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 4, 2023 August 04, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 25, 2023 July 25, 2023 Via Benzinga Marijuana Stock Movers For August 1, 2023 August 01, 2023 Via Benzinga Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking May 04, 2023 Via Benzinga Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details April 24, 2023 Via Benzinga Cannabis Stock Movers For July 27, 2023 July 27, 2023 Via Benzinga Olymbec Investments Increases Its Ownership In Cannara Biotech February 10, 2023 Via Benzinga Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA? January 23, 2023 Via Benzinga Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M November 28, 2022 Via Benzinga Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products September 20, 2022 Via Benzinga Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada August 03, 2022 Via Benzinga Cannara Biotech Revenue Grows 41% YoY, Here Are The Details July 27, 2022 Via Benzinga Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking June 02, 2022 Via Benzinga Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY April 27, 2022 Via Benzinga The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More December 10, 2021 Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA December 09, 2021 Via Benzinga Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.